Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis

Elevated serum levels of cardiac troponin and C-reactive protein are associated with all-cause and cardiovascular mortality in patients with end-stage renal disease. However, the relationship between these two biomarker levels and mortality in patients with chronic kidney disease remains unclear. We...

Full description

Bibliographic Details
Main Authors: Wei-Jie Li, Xu-Miao Chen, Xiao-Ying Nie, Jing Zhang, Yun-Jiu Cheng, Xiao-Xiong Lin, Su-Hua Wu
Format: Article
Language:English
Published: Elsevier España 2015-04-01
Series:Clinics
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000400301&lng=en&tlng=en
_version_ 1811228480559382528
author Wei-Jie Li
Xu-Miao Chen
Xiao-Ying Nie
Jing Zhang
Yun-Jiu Cheng
Xiao-Xiong Lin
Su-Hua Wu
author_facet Wei-Jie Li
Xu-Miao Chen
Xiao-Ying Nie
Jing Zhang
Yun-Jiu Cheng
Xiao-Xiong Lin
Su-Hua Wu
author_sort Wei-Jie Li
collection DOAJ
description Elevated serum levels of cardiac troponin and C-reactive protein are associated with all-cause and cardiovascular mortality in patients with end-stage renal disease. However, the relationship between these two biomarker levels and mortality in patients with chronic kidney disease remains unclear. We conducted a meta-analysis to quantify the association of cardiac troponin and C-reactive protein levels with all-cause and cardiovascular mortality in patients with chronic kidney disease. Relevant studies were identified by searching the MEDLINE database through November 2013. Studies were included in the meta-analysis if they reported the long-term all-cause or cardiovascular mortality of chronic kidney disease patients with abnormally elevated serum levels of cardiac troponin or C-reactive protein. Summary estimates of association were obtained using a random-effects model. Thirty-two studies met our inclusion criteria. From the pooled analysis, cardiac troponin and C-reactive protein were significantly associated with all-cause (HR 2.93, 95% CI 1.97-4.33 and HR 1.21, 95% CI 1.14-1.29, respectively) and cardiovascular (HR 3.27, 95% CI 1.67-6.41 and HR 1.19, 95% CI 1.10-1.28, respectively) mortality. In the subgroup analysis of cardiac troponin and C-reactive protein, significant heterogeneities were found among the subgroups of population for renal replacement therapy and for the proportion of smokers and the C-reactive protein analysis method. Elevated serum levels of cardiac troponin and C-reactive protein are significant associated with higher risks of all-cause and cardiovascular mortality in patients with chronic kidney disease. Further studies are warranted to explore the risk stratification in chronic kidney disease patients.
first_indexed 2024-04-12T09:58:32Z
format Article
id doaj.art-5630a224dff146c990d599ea1f2ecd8d
institution Directory Open Access Journal
issn 1980-5322
language English
last_indexed 2024-04-12T09:58:32Z
publishDate 2015-04-01
publisher Elsevier España
record_format Article
series Clinics
spelling doaj.art-5630a224dff146c990d599ea1f2ecd8d2022-12-22T03:37:37ZengElsevier EspañaClinics1980-53222015-04-0170430131110.6061/clinics/2015(04)14S1807-59322015000400301Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysisWei-Jie LiXu-Miao ChenXiao-Ying NieJing ZhangYun-Jiu ChengXiao-Xiong LinSu-Hua WuElevated serum levels of cardiac troponin and C-reactive protein are associated with all-cause and cardiovascular mortality in patients with end-stage renal disease. However, the relationship between these two biomarker levels and mortality in patients with chronic kidney disease remains unclear. We conducted a meta-analysis to quantify the association of cardiac troponin and C-reactive protein levels with all-cause and cardiovascular mortality in patients with chronic kidney disease. Relevant studies were identified by searching the MEDLINE database through November 2013. Studies were included in the meta-analysis if they reported the long-term all-cause or cardiovascular mortality of chronic kidney disease patients with abnormally elevated serum levels of cardiac troponin or C-reactive protein. Summary estimates of association were obtained using a random-effects model. Thirty-two studies met our inclusion criteria. From the pooled analysis, cardiac troponin and C-reactive protein were significantly associated with all-cause (HR 2.93, 95% CI 1.97-4.33 and HR 1.21, 95% CI 1.14-1.29, respectively) and cardiovascular (HR 3.27, 95% CI 1.67-6.41 and HR 1.19, 95% CI 1.10-1.28, respectively) mortality. In the subgroup analysis of cardiac troponin and C-reactive protein, significant heterogeneities were found among the subgroups of population for renal replacement therapy and for the proportion of smokers and the C-reactive protein analysis method. Elevated serum levels of cardiac troponin and C-reactive protein are significant associated with higher risks of all-cause and cardiovascular mortality in patients with chronic kidney disease. Further studies are warranted to explore the risk stratification in chronic kidney disease patients.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000400301&lng=en&tlng=enRenal insufficiencyMortalityTroponinC-reactive proteinMeta-analysis
spellingShingle Wei-Jie Li
Xu-Miao Chen
Xiao-Ying Nie
Jing Zhang
Yun-Jiu Cheng
Xiao-Xiong Lin
Su-Hua Wu
Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis
Clinics
Renal insufficiency
Mortality
Troponin
C-reactive protein
Meta-analysis
title Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis
title_full Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis
title_fullStr Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis
title_full_unstemmed Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis
title_short Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: A meta-analysis
title_sort cardiac troponin and c reactive protein for predicting all cause and cardiovascular mortality in patients with chronic kidney disease a meta analysis
topic Renal insufficiency
Mortality
Troponin
C-reactive protein
Meta-analysis
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322015000400301&lng=en&tlng=en
work_keys_str_mv AT weijieli cardiactroponinandcreactiveproteinforpredictingallcauseandcardiovascularmortalityinpatientswithchronickidneydiseaseametaanalysis
AT xumiaochen cardiactroponinandcreactiveproteinforpredictingallcauseandcardiovascularmortalityinpatientswithchronickidneydiseaseametaanalysis
AT xiaoyingnie cardiactroponinandcreactiveproteinforpredictingallcauseandcardiovascularmortalityinpatientswithchronickidneydiseaseametaanalysis
AT jingzhang cardiactroponinandcreactiveproteinforpredictingallcauseandcardiovascularmortalityinpatientswithchronickidneydiseaseametaanalysis
AT yunjiucheng cardiactroponinandcreactiveproteinforpredictingallcauseandcardiovascularmortalityinpatientswithchronickidneydiseaseametaanalysis
AT xiaoxionglin cardiactroponinandcreactiveproteinforpredictingallcauseandcardiovascularmortalityinpatientswithchronickidneydiseaseametaanalysis
AT suhuawu cardiactroponinandcreactiveproteinforpredictingallcauseandcardiovascularmortalityinpatientswithchronickidneydiseaseametaanalysis